NCT05840926View on ClinicalTrials.gov

Probiotic S. Salivarius K12 for the Prevention of Upper Respiratory Tract Infection in Nursery-age Children

NACompletedINTERVENTIONAL
Enrollment

287

Participants

Timeline

Start Date

January 5, 2022

Primary Completion Date

December 20, 2022

Study Completion Date

March 31, 2023

Conditions
Upper Respiratory Tract Infection
Interventions
DIETARY_SUPPLEMENT

Probiotic Streptococcus salivarius K12

Oral 1 billion CFU of Probiotic Streptococcus salivarius K12

OTHER

No probiotic supplementation

Children who did not receive any probiotic supplementation

Trial Locations (1)

Unknown

Liaquat University Hospital, Jāmshoro

All Listed Sponsors
lead

Liaquat University of Medical & Health Sciences

OTHER

NCT05840926 - Probiotic S. Salivarius K12 for the Prevention of Upper Respiratory Tract Infection in Nursery-age Children | Biotech Hunter | Biotech Hunter